Ionis Pharmaceuticals Stock Target Price and Analyst Consensus

IONS Stock  USD 78.53  1.14  1.43%   
The current analyst and expert consensus on Ionis Pharmaceuticals is Strong Buy with 8 hold recommendations. The current projected Ionis Pharmaceuticals target price consensus is 87.99 with 26 analyst opinions. One of the most common ways Ionis Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Ionis Pharmaceuticals vendors, executives, and/or customers. Ionis Pharmaceuticals recommendation module provides expert sentiment on the projected Ionis Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 1.8396.
Lowest Forecast
80.07
Highest Forecast
97.67
Target Price
87.99
Gross Profit is likely to gain to about 837.9 M in 2026, despite the fact that Pretax Profit Margin is likely to grow to (0.56). At this time, Ionis Pharmaceuticals' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 104.2 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 86.2 M in 2026.
It's important to approach Ionis Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Ionis Pharmaceuticals Target Price Consensus

Ionis target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Ionis Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   26  Strong Buy
Most Ionis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Ionis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Ionis Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Ionis Pharmaceuticals Target Price Projection

Ionis Pharmaceuticals' current and average target prices are 78.53 and 87.99, respectively. The current price of Ionis Pharmaceuticals is the price at which Ionis Pharmaceuticals is currently trading. On the other hand, Ionis Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Ionis Pharmaceuticals Market Quote on 5th of January 2026

Low Price76.58Odds
High Price80.21Odds

78.53

Target Price

Analyst Consensus On Ionis Pharmaceuticals Target Price

Low Estimate80.07Odds
High Estimate97.67Odds

87.9891

Historical Lowest Forecast  80.07 Target Price  87.99 Highest Forecast  97.67
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Ionis Pharmaceuticals and the information provided on this page.

Ionis Pharmaceuticals Analyst Ratings

Ionis Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Ionis Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Ionis Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Ionis Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Ionis Pharmaceuticals price targets

Ionis Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Ionis Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Ionis Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ionis Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Ionis Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ionis Pharmaceuticals is a key component of Ionis Pharmaceuticals valuation and have some predictive power on the future returns of a Ionis Pharmaceuticals.
Hype
Prediction
LowEstimatedHigh
74.7376.6378.53
Details
Intrinsic
Valuation
LowRealHigh
68.9289.0590.95
Details
Naive
Forecast
LowNextHigh
77.0778.9780.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.65-0.49-0.34
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
ESG Investing Idea
ESG Investing
Invested few shares
Robots And Drones Idea
Robots And Drones
Invested over 60 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested one share
Dividend Beast Idea
Dividend Beast
Invested over 40 shares
Buywrite ETFs Idea
Buywrite ETFs
Invested over 300 shares
IT Idea
IT
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.